Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (PlA1).

Zhi H, Ahlen MT, Thinn AMM, Weiler H, Curtis BR, Skogen B, Zhu J, Newman PJ.

Blood Adv. 2018 Nov 13;2(21):3001-3011. doi: 10.1182/bloodadvances.2018023341.

2.

Screening for fetal and neonatal alloimmune thrombocytopenia - lessons learned from a Norwegian screening program.

Kjaer M, Kjeldsen-Kragh J, Fiskum C, Leinan I, Skogen B, Husebekk A.

Acta Obstet Gynecol Scand. 2018 Jun;97(6):766-767. doi: 10.1111/aogs.13320. Epub 2018 Mar 5. No abstract available.

PMID:
29412452
3.

Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.

Kjær M, Tiller H, Heide G, Kjeldsen-Kragh J, Skogen B, Husebekk A.

PLoS One. 2017 Aug 24;12(8):e0182957. doi: 10.1371/journal.pone.0182957. eCollection 2017.

4.

Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-Antibody specificity analysis using epitope data.

Dahl J, Refsum E, Ahlen MT, Egeland T, Jensen T, Viken MK, Stuge TB, Acharya G, Husebekk A, Skogen B, Tiller H.

J Reprod Immunol. 2017 Aug;122:1-9. doi: 10.1016/j.jri.2017.06.003. Epub 2017 Jun 27.

PMID:
28686909
5.

Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.

Tiller H, Husebekk A, Ahlen MT, Stuge TB, Skogen B.

Int J Womens Health. 2017 Apr 19;9:223-234. doi: 10.2147/IJWH.S90753. eCollection 2017. Review.

6.

Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model.

Eksteen M, Heide G, Tiller H, Zhou Y, Nedberg NH, Martinez-Zubiaurre I, Husebekk A, Skogen BR, Stuge TB, Kjær M.

Reprod Biol Endocrinol. 2017 Apr 21;15(1):28. doi: 10.1186/s12958-017-0245-6.

7.

T cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition.

Ahlen MT, Husebekk A, Killie IL, Skogen B, Stuge TB.

JCI Insight. 2016 Sep 8;1(14):e86558. doi: 10.1172/jci.insight.86558.

8.

Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia.

Weng YJ, Husebekk A, Skogen B, Kjaer M, Lin LT, Burnouf T.

PLoS One. 2016 Sep 14;11(9):e0162973. doi: 10.1371/journal.pone.0162973. eCollection 2016.

9.

Platelet antibody identification: toward a solution.

Skogen B.

Blood. 2016 Feb 11;127(6):665-6. doi: 10.1182/blood-2015-12-686634. No abstract available.

PMID:
26869303
10.

Old tools revisited give hope - new treatment option for families with a history of severe FNAIT complications.

Tiller H, Fedorcsak P, Skogen BR.

Acta Obstet Gynecol Scand. 2016 Apr;95(4):486-7. doi: 10.1111/aogs.12842. Epub 2016 Jan 14. No abstract available.

PMID:
26669518
11.

Maternal anti-HLA class I antibodies are associated with reduced birth weight in thrombocytopenic neonates.

Dahl J, Husebekk A, Acharya G, Flo K, Stuge TB, Skogen B, Straume B, Tiller H.

J Reprod Immunol. 2016 Feb;113:27-34. doi: 10.1016/j.jri.2015.10.003. Epub 2015 Oct 29.

PMID:
26547815
12.

Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy.

Eksteen M, Tiller H, Averina M, Heide G, Kjaer M, Ghevaert C, Michaelsen TE, Ihle Ø, Husebekk A, Skogen B, Stuge TB.

J Immunol. 2015 Jun 15;194(12):5751-60. doi: 10.4049/jimmunol.1401599. Epub 2015 May 13.

13.

Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.

Yougbaré I, Lang S, Yang H, Chen P, Zhao X, Tai WS, Zdravic D, Vadasz B, Li C, Piran S, Marshall A, Zhu G, Tiller H, Killie MK, Boyd S, Leong-Poi H, Wen XY, Skogen B, Adamson SL, Freedman J, Ni H.

J Clin Invest. 2015 Apr;125(4):1545-56. doi: 10.1172/JCI77820. Epub 2015 Mar 16.

14.

True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study.

Tiller H, Husebekk A, Skogen B, Kjeldsen-Kragh J, Kjaer M.

BJOG. 2016 Apr;123(5):738-44. doi: 10.1111/1471-0528.13343. Epub 2015 Mar 9.

15.

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.

Kapur R, Kustiawan I, Vestrheim A, Koeleman CA, Visser R, Einarsdottir HK, Porcelijn L, Jackson D, Kumpel B, Deelder AM, Blank D, Skogen B, Killie MK, Michaelsen TE, de Haas M, Rispens T, van der Schoot CE, Wuhrer M, Vidarsson G.

Blood. 2014 Jan 23;123(4):471-80. doi: 10.1182/blood-2013-09-527978. Epub 2013 Nov 15.

16.

Mechanisms and prevention of alloimmunization in pregnancy.

Kjeldsen-Kragh J, Skogen B.

Obstet Gynecol Surv. 2013 Jul;68(7):526-32. doi: 10.1097/OGX.0b013e3182947ce4. Review.

PMID:
23803755
17.

The DR7-DQ2 haplotype in a native Norwegian population.

Heide G, Stuge TB, Skogen B, Husebekk A, Ahlen MT.

Scand J Immunol. 2013 May;77(5):429-30. doi: 10.1111/sji.12031. No abstract available.

18.

Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.

Kjeldsen-Kragh J, Ni H, Skogen B.

Curr Opin Hematol. 2012 Nov;19(6):469-74. doi: 10.1097/MOH.0b013e328358f86c. Review.

PMID:
22954726
19.

Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.

Husebekk A, El Ekiaby M, Gorgy G, Killie MK, Uhlin-Hansen C, Salma W, Navarrete C, El Afandi M, Skogen B, Ahlen MT.

Transfus Apher Sci. 2012 Dec;47(3):277-82. doi: 10.1016/j.transci.2012.04.001. Epub 2012 May 27.

PMID:
22640833
20.

Thanks for the respect.

Skogen BJ.

Minn Med. 2011 Nov;94(11):6. No abstract available.

PMID:
22413636
21.

Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.

Tiller H, Killie MK, Chen P, Eksteen M, Husebekk A, Skogen B, Kjeldsen-Kragh J, Ni H.

Transfusion. 2012 Jul;52(7):1446-57. doi: 10.1111/j.1537-2995.2011.03480.x. Epub 2012 Jan 17.

PMID:
22251227
22.

The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.

Ahlen MT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Olsson ML, Skogen B.

Clin Dev Immunol. 2012;2012:156867. doi: 10.1155/2012/156867. Epub 2011 Nov 2.

23.

Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys.

Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Øian P.

Acta Obstet Gynecol Scand. 2012 Jan;91(1):79-86. doi: 10.1111/j.1600-0412.2011.01269.x. Epub 2011 Oct 13.

PMID:
21895612
24.

The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data.

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B.

Blood. 2011 Sep 1;118(9):2638-9. doi: 10.1182/blood-2011-06-360404. No abstract available.

PMID:
21885616
25.

The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopenia.

Stuge TB, Skogen B, Ahlen MT, Husebekk A, Urbaniak SJ, Bessos H.

Transfus Apher Sci. 2011 Aug;45(1):53-9. doi: 10.1016/j.transci.2011.06.003. Epub 2011 Jun 25. Review.

PMID:
21708486
26.

Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.

Skogen B, Killie MK, Kjeldsen-Kragh J, Ahlen MT, Tiller H, Stuge TB, Husebekk A.

Expert Rev Hematol. 2010 Oct;3(5):559-66. doi: 10.1586/ehm.10.49. Review.

PMID:
21083473
27.

Quantitative MAIPA: Comparison of different MAIPA protocols.

Killie MK, Salma W, Bertelsen E, Skogen B, Husebekk A.

Transfus Apher Sci. 2010 Oct;43(2):149-54. doi: 10.1016/j.transci.2010.07.001. Epub 2010 Aug 2.

PMID:
20675194
28.

Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from a large prospective screening and intervention program.

Skogen B, Husebekk A, Killie MK, Kjeldsen-Kragh J.

Scand J Immunol. 2009 Dec;70(6):531-4. doi: 10.1111/j.1365-3083.2009.02339.x. Review.

29.

Is it time to implement HPA-1 screening in pregnancy?

Husebekk A, Killie MK, Kjeldsen-Kragh J, Skogen B.

Curr Opin Hematol. 2009 Nov;16(6):497-502. doi: 10.1097/MOH.0b013e3283317be9. Review.

PMID:
19730261
30.

Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme.

Tiller H, Killie MK, Skogen B, Øian P, Husebekk A.

BJOG. 2009 Mar;116(4):594-8. doi: 10.1111/j.1471-0528.2008.02068.x.

31.

The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia - Where does it stand?

Bessos H, Killie MK, Seghatchian J, Skogen B, Urbaniak SJ.

Transfus Apher Sci. 2009 Apr;40(2):75-8. doi: 10.1016/j.transci.2009.01.010. Epub 2009 Feb 14.

PMID:
19223235
32.

T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells.

Ahlen MT, Husebekk A, Killie MK, Skogen B, Stuge TB.

Blood. 2009 Apr 16;113(16):3838-44. doi: 10.1182/blood-2008-09-178475. Epub 2009 Jan 9.

PMID:
19136661
33.

Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B.

Transfus Apher Sci. 2008 Jun;38(3):183-8. doi: 10.1016/j.transci.2008.04.010. Epub 2008 May 21. Review.

PMID:
18499524
34.

A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn.

Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B.

Haematologica. 2008 Jun;93(6):870-7. doi: 10.3324/haematol.12515. Epub 2008 Apr 28.

35.

Monoclonal platelet antigen capture assays (MAIPA) and reagents: a statement.

Kaplan C, Freedman J, Foxcroft Z, Husebekk A, Metcalfe P, Muniz-Diaz E, Ouwehand W, Panzer S, Rozman P, Skogen B; International Society of Blood Transfusion--Working Party on Platelet Immunology.

Vox Sang. 2007 Nov;93(4):298-9.

PMID:
18070272
36.

The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations.

Valentin N, Gagne K, Kerdudou N, Hallé L, Kaplan C, Killie MK, Skogen B, Muller JY, Bignon JD.

Transfusion. 2007 Dec;47(12):2322-9. Epub 2007 Aug 21.

PMID:
17714418
37.

A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia.

Kjeldsen-Kragh J, Killie MK, Tomter G, Golebiowska E, Randen I, Hauge R, Aune B, Øian P, Dahl LB, Pirhonen J, Lindeman R, Husby H, Haugen G, Grønn M, Skogen B, Husebekk A.

Blood. 2007 Aug 1;110(3):833-9. Epub 2007 Apr 11.

PMID:
17429009
38.

Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia.

Killie MK, Kjeldsen-Kragh J, Husebekk A, Skogen B, Olsen JA, Kristiansen IS.

BJOG. 2007 May;114(5):588-95. Epub 2007 Mar 13. Erratum in: BJOG. 2007 Nov;114(11):1453.

39.

Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study.

Killie MK, Husebekk A, Kaplan C, Taaning E, Skogen B.

Transfusion. 2007 Jan;47(1):55-8.

PMID:
17207230
40.

Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL.

Gruber FX, Lamark T, Anonli A, Sovershaev MA, Olsen M, Gedde-Dahl T, Hjort-Hansen H, Skogen B.

Leukemia. 2005 Dec;19(12):2159-65.

PMID:
16224487
41.

Coeliac disease in subjects with secondary hyperparathyroidism.

Jorde R, Saleh F, Sundsfjord J, Haug E, Skogen B.

Scand J Gastroenterol. 2005 Feb;40(2):178-82.

PMID:
15764148
42.

Hepatitis B virus-infected peripheral blood progenitor cell harvests in liquid nitrogen freezer containing non-infectious products.

Husebekk A, Skaug K, Kolstad A, Dahl IM, Gutteberg T, Skogen B.

Transfusion. 2004 Jun;44(6):942-3. No abstract available.

PMID:
15157265
43.

Evaluation of a new flow cytometric HPA 1a screening method. A rapid and reliable tool for HPA 1a screening of blood donors and pregnant women.

Killie MK, Kjeldsen-Kragh J, Randen I, Skogen B, Husebekk A.

Transfus Apher Sci. 2004 Apr;30(2):89-92.

PMID:
15062744
45.

[Significance of maternal alloantibodies for neonatal thrombocytopenia].

Husebekk A, Skogen B.

Tidsskr Nor Laegeforen. 2001 Nov 10;121(27):3160-2. Norwegian.

46.
47.

Does anti-D protect platelets from anti-HPA 1A mediated destruction?

Husebekk A, Jaegtvik S, Aune B, Oian P, Dahl LB, Skogen B.

Br J Haematol. 1999 Sep;106(3):835. No abstract available.

PMID:
10468884
48.

[Decentralized high-dose cytostatic treatment with autologous stem cell support].

Husebekk A, Kolstad A, Dahl IM, Skogen B.

Tidsskr Nor Laegeforen. 1998 Aug 10;118(18):2777-80. Norwegian.

PMID:
9748807
49.

One-tube method for complete HPA-1 genotyping by PCR using sequence-specific primers.

Boldt B, Skogen B, Agostini T, Roscetti D, McFarland J.

Br J Haematol. 1997 Dec;99(4):968-73.

PMID:
9432051

Supplemental Content

Loading ...
Support Center